PEG-MGF Dosage Guide
Complete guide to PEG-MGF dosing protocols, administration methods, and safety considerations for research purposes.
Dosage Overview
Dose per Injection
400 mcg – 1.2 mg
Frequency
Once per week
Route
subcutaneous
Cycle Length
4–6 weeks
Reconstitution
Vial Size
2 mg
BAC Water
2.0 ml
Concentration
1,000 mcg/ml
Detailed Dosage Information
Research protocols typically use 200-400mcg injected into targeted muscle groups 2-3 times weekly, usually post-workout.
Administration Method
Intramuscular injection, ideally into muscles trained that day. Best administered post-workout when satellite cell activation is relevant.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Concentration: 1 mg/ml
Volume to inject: 0.800 ml
Syringe units: 80.0 units
U-100 insulin syringe (100 units = 1 ml). Verify dose with a clinician before injecting.
Pre-filled with PEG-MGF defaults. Adjust values as needed.
Side Effects to Monitor
Injection site soreness, potential hypoglycemia, and localized swelling. Generally well-tolerated.
Safety Considerations & Risks
Limited human research. May promote unwanted tissue growth. Quality and purity concerns with research products.